Nurses: Hazardous Substances
The question
To ask the Secretary of State for Health and Social Care, what research his Department has commissioned on (a) reproductive health outcomes and (b) long‑term health effects of the occupational exposure of nursing staff to hazardous medicinal products; and what estimate he has made of the cost to the NHS of sickness absence related to such exposure.
Answered by Dr Zubir Ahmed
The Government has not commissioned any research on the reproductive health outcomes or long-term health effects of the occupational exposure of nursing staff to hazardous medicinal products. No assessment has been made of the cost to the National Health Service of sickness absence related to this.
Sickness absence is managed at an organisational level across the NHS. NHS organisations have their own policies and procedures in place to manage and reduce sickness absence, including any reasonable adjustments to allow people to return to work and/or prevent future absence. It is important that employers across the NHS take a preventative and proactive approach to supporting their staff and keeping them healthy.
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →